BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumita S, Yoshinaga K, Miyagawa M, Momose M, Kiso K, Kasai T, Naya M; Committee for diagnosis of cardiac sarcoidosis using 18F-FDG PET, Japanese Society of Nuclear Cardiology. Recommendations for 18F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis—2018 update: Japanese Society of Nuclear Cardiology recommendations. J Nucl Cardiol 2019;26:1414-33. [DOI: 10.1007/s12350-019-01755-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Manabe O, Naya M, Aikawa T, Tamaki N. Recent advances in cardiac positron emission tomography for quantitative perfusion analyses and molecular imaging. Ann Nucl Med 2020;34:697-706. [DOI: 10.1007/s12149-020-01519-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Sharma A, Okada DR, Yacoub H, Chrispin J, Bokhari S. Diagnosis of cardiac sarcoidosis: an era of paradigm shift. Ann Nucl Med 2020;34:87-93. [DOI: 10.1007/s12149-019-01431-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
3 Li Q, Hou W, Li L, Su M, Ren Y, Wang W, Zou K, Tian R, Sun X. The use of systematic review evidence to support the development of guidelines for positron emission tomography: a cross-sectional survey. Eur Radiol 2021;31:6992-7002. [PMID: 33683391 DOI: 10.1007/s00330-021-07756-6] [Reference Citation Analysis]
4 Manabe O, Oyama-Manabe N, Tamaki N. Positron emission tomography/MRI for cardiac diseases assessment. Br J Radiol 2020;93:20190836. [PMID: 32023123 DOI: 10.1259/bjr.20190836] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Slart RHJA, Glaudemans AWJM, Gheysens O, Lubberink M, Kero T, Dweck MR, Habib G, Gaemperli O, Saraste A, Gimelli A, Georgoulias P, Verberne HJ, Bucerius J, Rischpler C, Hyafil F, Erba PA; 4Is Cardiovascular Imaging: a joint initiative of the European Association of Cardiovascular Imaging (EACVI) and the European Association of Nuclear Medicine (EANM). Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation- (4Is) related cardiovascular diseases: a joint collaboration of the EACVI and the EANM: summary. Eur Heart J Cardiovasc Imaging 2020;21:1320-30. [PMID: 33245759 DOI: 10.1093/ehjci/jeaa299] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
6 Scholtens AM. 18F-Fluorodeoxyglucose PET/Computed Tomography in Endocarditis. PET Clinics 2020;15:187-95. [DOI: 10.1016/j.cpet.2019.11.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Sankjmiron SS, Kyprianou K, Cherk MH, Nadebaum DP, Beech PA, Khor R, Zimmet H, Hare JL, Larby A, Yap KS, Barber TW. Excellent suppression of physiological myocardial FDG activity in patients with cardiac sarcoidosis. J Med Imaging Radiat Oncol 2021;65:54-9. [PMID: 33103345 DOI: 10.1111/1754-9485.13121] [Reference Citation Analysis]
8 Chujo K, Norikane T, Murao M, Takami Y, Mitamura K, Yamamoto Y, Fujita H, Nishiyama Y. Incidental 18F-FDG myocardial uptake revealed as physiological lesion by 18F-FLT PET/CT. J Nucl Cardiol 2021. [PMID: 33890185 DOI: 10.1007/s12350-021-02618-6] [Reference Citation Analysis]
9 Kato S, Aikawa T, Ibe T, Manabe O, Oyama-Manabe N. Delayed 18F-fluorodeoxyglucose PET/CT imaging improves detection of cardiac involvement in sarcoidosis. J Nucl Cardiol 2021. [PMID: 34657978 DOI: 10.1007/s12350-021-02815-3] [Reference Citation Analysis]
10 Dietz M, Paulmier B, Berthier F, Civaia F, Mocquot F, Serrano B, Nataf V, Hugonnet F, Faraggi M. An Intravenous 100-mL Lipid Emulsion Infusion Dramatically Improves Myocardial Glucose Metabolism Extinction in Cardiac FDG PET Clinical Practice. Clin Nucl Med 2021;46:e317-24. [PMID: 33630808 DOI: 10.1097/RLU.0000000000003556] [Reference Citation Analysis]
11 Osiecki S, Sterliński M, Marciniak-Emmons M, Dziuk M. Feasibility of 18FDG PET in the cardiac inflammation. Int J Cardiovasc Imaging 2021;37:1097-104. [PMID: 33063243 DOI: 10.1007/s10554-020-02056-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Hess S, Scholtens AM, Gormsen LC. Patient Preparation and Patient-related Challenges with FDG-PET/CT in Infectious and Inflammatory Disease. PET Clin 2020;15:125-34. [PMID: 32145883 DOI: 10.1016/j.cpet.2019.11.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Manapragada PP, Andrikopoulou E, Bajaj N, Bhambhvani P. PET Cardiac Imaging (Perfusion, Viability, Sarcoidosis, and Infection). Radiol Clin North Am 2021;59:835-52. [PMID: 34392922 DOI: 10.1016/j.rcl.2021.05.009] [Reference Citation Analysis]
14 Liu ET, Sun TT, Dong HJ, Wang SY, Chen ZR, Liu C, Shao D, Lian ZY, Xie Q, Wang SX. Combined PET/CT with thoracic contrast-enhanced CT in assessment of primary cardiac tumors in adult patients. EJNMMI Res 2020;10:75. [PMID: 32632639 DOI: 10.1186/s13550-020-00661-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Mathai SV, Patel S, Jorde UP, Rochlani Y. Epidemiology, Pathogenesis, and Diagnosis of Cardiac Sarcoidosis. Methodist DeBakey Cardiovascular Journal 2022;18:78-93. [DOI: 10.14797/mdcvj.1057] [Reference Citation Analysis]
16 Kong E. F-18 fluorodeoxyglucose positron emission tomography/computed tomography in the infection of heart. Yeungnam Univ J Med 2021;38:95-106. [PMID: 33053614 DOI: 10.12701/yujm.2020.00479] [Reference Citation Analysis]
17 Scholtens AM, van den Berk AM, van der Sluis NL, Esser JP, Lammers GK, de Klerk JMH, Lam MGEH, Verberne HJ. Suppression of myocardial glucose metabolism in FDG PET/CT: impact of dose variation in heparin bolus pre-administration. Eur J Nucl Med Mol Imaging 2020;47:2698-702. [PMID: 32198612 DOI: 10.1007/s00259-020-04713-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
18 Greulich S, Gatidis S, Gräni C, Blankstein R, Glatthaar A, Mezger K, Müller KAL, Castor T, Mahrholdt H, Häntschel M, Hetzel J, Dittmann H, Nikolaou K, Gawaz M, la Fougère C, Krumm P. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis. JACC Cardiovasc Imaging 2021:S1936-878X(21)00685-9. [PMID: 34656480 DOI: 10.1016/j.jcmg.2021.08.018] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Manabe O, Oyama-Manabe N, Aikawa T, Tsuneta S, Tamaki N. Advances in Diagnostic Imaging for Cardiac Sarcoidosis. J Clin Med 2021;10:5808. [PMID: 34945105 DOI: 10.3390/jcm10245808] [Reference Citation Analysis]
20 Slart RHJA, Glaudemans AWJM, Gheysens O, Lubberink M, Kero T, Dweck MR, Habib G, Gaemperli O, Saraste A, Gimelli A, Georgoulias P, Verberne HJ, Bucerius J, Rischpler C, Hyafil F, Erba PA; 4Is Cardiovascular Imaging: a joint initiative of the European Association of Cardiovascular Imaging (EACVI)., European Association of Nuclear Medicine (EANM). Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular diseases: a joint collaboration of the EACVI and the EANM. Eur J Nucl Med Mol Imaging 2021;48:1016-39. [PMID: 33106926 DOI: 10.1007/s00259-020-05066-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
21 AlJaroudi WA, Hage FG. Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2019: Positron emission tomography, computed tomography and magnetic resonance. J Nucl Cardiol 2020;27:921-30. [PMID: 32410058 DOI: 10.1007/s12350-020-02151-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Tanaka H, Hosono M, Kanagaki M, Shimizu M, Matsubara N, Kawabata K, Miyamoto T, Itoi K. A case of cardiac amyloidosis incidentally detected by bone scintigraphy. Asia Ocean J Nucl Med Biol 2021;9:71-5. [PMID: 33392354 DOI: 10.22038/AOJNMB.2020.50508.1350] [Reference Citation Analysis]